Financial Position - Total assets at the end of the reporting period were CNY 5,366,092,484, a decrease of 0.84% compared to the end of the previous year[8]. - Equity attributable to shareholders of the listed company was CNY 3,660,102,848.95, down 0.65% from the previous year[8]. - Long-term equity investments amounted to CNY 213,663,052.13, a slight decrease from CNY 216,938,901.85[14]. - Other equity instrument investments increased to CNY 456,862,467.76 from CNY 454,328,054.74[14]. - The total liabilities included contract liabilities of CNY 1,129,632,678.33, slightly down from CNY 1,134,216,178.42[14]. - Total liabilities decreased from RMB 1,612,743,955.98 to RMB 1,590,089,692.84, a reduction of approximately 1.0%[27]. - Non-current liabilities decreased from RMB 131,006,703.81 to RMB 126,427,284.42, a decrease of about 3.5%[27]. - The total equity attributable to shareholders decreased from RMB 3,684,062,269.13 to RMB 3,660,102,848.95, a decline of approximately 0.65%[27]. - The company's capital reserve remained stable at RMB 3,377,070,202.21, with a slight decrease in the previous period[27]. - The deferred income tax liabilities decreased from RMB 23,151,133.57 to RMB 22,432,553.08, a reduction of approximately 3.1%[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 35,081[10]. - The top shareholder, Tianjin Deyuan Health Management Co., Ltd., holds 12.14% of the shares, totaling 56,787,503 shares[23]. - The total number of shareholders at the end of the reporting period was not specified, but the report indicates changes in the top ten shareholders due to stock lending activities[61]. Income and Profitability - The company reported a net loss of RMB 277,282,776.96, an improvement from a loss of RMB 317,432,265.76 in the previous period[27]. - The company's total operating revenue for Q1 2024 was CNY 397,981,195.71, representing a year-over-year increase of 5.36%[45]. - The net profit attributable to shareholders of the listed company was CNY 40,149,488.80, up 7.43% compared to the same period last year[45]. - The total profit for Q1 2024 was ¥56,753,233.47, compared to ¥48,689,834.90 in Q1 2023, indicating a year-over-year increase of about 16.5%[67]. - The company's operating profit reached ¥56,740,467.97, up from ¥48,502,742.39 in the previous year, marking a growth of approximately 17%[67]. - The net profit attributable to shareholders of the parent company was ¥40,149,488.80, compared to ¥37,373,824.55 in Q1 2023, reflecting an increase of around 7.5%[67]. - The total comprehensive income attributable to the parent company's owners was CNY 33,380,014.46, compared to CNY 25,156,748.58 in the same period last year[54]. - The company reported a total comprehensive income of ¥34,730,937.04 for Q1 2024, compared to ¥23,039,552.43 in the same quarter last year, showing a significant increase of approximately 50.6%[67]. Cash Flow and Expenses - Cash inflow from operating activities was RMB 401,420,062.09, slightly down from RMB 402,970,860.77 in the previous year[39]. - The cash received from sales of goods and services was RMB 391,988,309.76, compared to RMB 396,302,851.84 in the previous year, indicating a decrease of about 1.0%[39]. - The net cash flow from operating activities was CNY 21,424,807.24, a decrease of 20.74% year-over-year[45]. - The net cash flow from investing activities was CNY -20,377,150.14, showing a slight improvement from CNY -22,644,005.19 in the previous year[45]. - Research and development expenses for Q1 2024 amounted to CNY 43,793,779.30, compared to CNY 33,453,290.77 in the same period last year[53]. - The total operating costs for Q1 2024 were CNY 337,152,485.72, an increase from CNY 323,064,529.03 in Q1 2023[53]. Share Repurchase and Future Plans - The company has repurchased a total of 6,181,212 shares, representing 1.32% of the total share capital, with a total expenditure of approximately RMB 99,995,028.04[33]. - The company plans to continue using RMB 50 million to RMB 100 million for share repurchase to support stock incentives[33]. Tax and Other Comprehensive Income - The income tax expense for Q1 2024 was ¥15,252,822.09, up from ¥13,433,206.50 in Q1 2023, which is an increase of about 13.5%[67]. - The company recorded other comprehensive income after tax of -¥6,769,474.34, an improvement from -¥12,217,075.97 in the previous year[67]. - The company did not identify any non-recurring gains or losses that were significant for this reporting period[59]. - The report does not provide specific guidance on future performance or new product developments[68].
中源协和(600645) - 2024 Q1 - 季度财报